Browse By Cell Line Result Page of OvirusTdb
The total number of records retrieved from this search are 4. Click on ID to see further detail.
IDOV_4641 | Virus nameMeasles virus | Virus strainrMV-SLAMblind | Virus genome typeRNA | Virus familyParamyxoviridae | Virus genome modificationR533A substitution was introduced into pMV-HL(7+) and then transfected to vero cell line to produce virus particle | Virus aloneYes | Virus in combination with drug/radiationNo | Immune gene insertion in viral genomeNo | Source of cell lineUnivesity of Tokyo Japan | Origin of cell lineCanine mammary cancer | Cell lineCHMm | Concentration of cell lineNA | In-vitro toxicityNA | AssayWST-1 assay | In-vitro virus concentration2 MOI | In-vitro result100% cell viability after 2 days | Model organismNo | In-vivo virus concentrationNo | In-vivo toxicityNA | In-vivo resultNo response | Mode of deliveryNA | Pathway inducedNA | Immunogenic effectNA | Clinical trialNA | PMID27093696 |
IDOV_4642 | Virus nameMeasles virus | Virus strainrMV-SLAMblind | Virus genome typeRNA | Virus familyParamyxoviridae | Virus genome modificationR533A substitution was introduced into pMV-HL(7+) and then transfected to vero cell line to produce virus particle | Virus aloneYes | Virus in combination with drug/radiationNo | Immune gene insertion in viral genomeNo | Source of cell lineUnivesity of Tokyo Japan | Origin of cell lineCanine mammary cancer | Cell lineCHMm | Concentration of cell lineNA | In-vitro toxicityNA | AssayWST-1 assay | In-vitro virus concentration2 MOI | In-vitro result40% cell viability after 4 days | Model organismNo | In-vivo virus concentrationNo | In-vivo toxicityNA | In-vivo resultNo response | Mode of deliveryNA | Pathway inducedNA | Immunogenic effectNA | Clinical trialNA | PMID27093696 |
IDOV_4643 | Virus nameMeasles virus | Virus strainrMV-SLAMblind | Virus genome typeRNA | Virus familyParamyxoviridae | Virus genome modificationR533A substitution was introduced into pMV-HL(7+) and then transfected to vero cell line to produce virus particle | Virus aloneYes | Virus in combination with drug/radiationNo | Immune gene insertion in viral genomeNo | Source of cell lineUnivesity of Tokyo Japan | Origin of cell lineCanine mammary cancer | Cell lineCHMm | Concentration of cell lineNA | In-vitro toxicityNA | AssayWST-1 assay | In-vitro virus concentration2 MOI | In-vitro result40% cell viability after 4 days | Model organismNo | In-vivo virus concentrationNo | In-vivo toxicityNA | In-vivo resultNo response | Mode of deliveryNA | Pathway inducedNA | Immunogenic effectNA | Clinical trialNA | PMID27093696 |
IDOV_4644 | Virus nameMeasles virus | Virus strainrMV-SLAMblind | Virus genome typeRNA | Virus familyParamyxoviridae | Virus genome modificationR533A substitution was introduced into pMV-HL(7+) and then transfected to vero cell line to produce virus particle | Virus aloneYes | Virus in combination with drug/radiationNo | Immune gene insertion in viral genomeNo | Source of cell lineUnivesity of Tokyo Japan | Origin of cell lineCanine mammary cancer | Cell lineCHMm | Concentration of cell lineNA | In-vitro toxicityNA | AssayWST-1 assay | In-vitro virus concentration2 MOI | In-vitro result40% cell viability after 4 days | Model organismNo | In-vivo virus concentrationNo | In-vivo toxicityNA | In-vivo resultNo response | Mode of deliveryNA | Pathway inducedNA | Immunogenic effectNA | Clinical trialNA | PMID27093696 |